Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

US Patent 11884748 · Granted Jan 30, 2024

Estimated economic value: $29,676,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lipidated peptide inhibitors of interleukin-23 receptor2025
Lipidated peptide inhibitors of interleukin-23 receptor2025
Program-read-erase schemes to protect PUF challenge-response-pairs with pre-form2025
Power adapter with removable plugs2025
Subgroup wireless operations on dynamic frequency selection (DFS) channels2025
Lipid pharmaceutical preparation and application thereof2025
Lens unit, optical lens, illumination module, vehicle light, and vehicle2025
Precious metal-supported eggshell catalyst as well as preparation method and use2025
Method for preparing quantum dot light-emitting diodes2025
Coaxial electric drive axle and automobile2025
CRISPR-Cas system for clostridium genome engineering and recombinant strains pro2025
Contraction joint for fiber optics intelligent completion2025